Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Weiden

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Cancer|March 1, 1992
A phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors. A Southwest Oncology Group studyJ E Mortimer, J Crowley, H Eyre, et al.
Cancer Investigation|June 2, 2000
Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancerA Jacobs, P Gold, P Weiden, et al.
Schizophrenia Bulletin|November 22, 2000
Prevalence and correlates of diabetes in national schizophrenia samplesL Dixon, P Weiden, J Delahanty, et al.
Schizophrenia Bulletin|January 1, 1994
Rating of medication influences (ROMI) scale in schizophreniaP Weiden, B Rapkin, T Mott, et al.
Psychopharmacology Bulletin|January 1, 1993
Treatment of neuroleptic-resistant schizophrenic relapseB J Kinon, J M Kane, C Johns, et al.
International Clinical Psychopharmacology|May 1, 1996
Transition from acute to maintenance treatment: prediction of stabilizationN R Schooler, J B Severe, I D Glick, et al.
Progress in Clinical and Biological Research|January 1, 1987
Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantationA Fefer, K M Sullivan, P Weiden, et al.
Progress in Clinical and Biological Research|January 1, 1987
Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantationK M Sullivan, A Fefer, R Witherspoon, et al.
Obstetrics and Gynecology|October 1, 1993
A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical responseA J Jacobs, M Fer, F M Su, et al.
CNS Spectrums|August 23, 2005
An innovative approach to clinical communication in schizophrenia: the approaches to schizophrenia communication checklistsS G Dott, P Weiden, P Hopwood, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cancer|March 1, 1992
A phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors. A Southwest Oncology Group studyJ E Mortimer, J Crowley, H Eyre, et al.
Cancer Investigation|June 2, 2000
Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancerA Jacobs, P Gold, P Weiden, et al.
Schizophrenia Bulletin|November 22, 2000
Prevalence and correlates of diabetes in national schizophrenia samplesL Dixon, P Weiden, J Delahanty, et al.
Schizophrenia Bulletin|January 1, 1994
Rating of medication influences (ROMI) scale in schizophreniaP Weiden, B Rapkin, T Mott, et al.
Psychopharmacology Bulletin|January 1, 1993
Treatment of neuroleptic-resistant schizophrenic relapseB J Kinon, J M Kane, C Johns, et al.
International Clinical Psychopharmacology|May 1, 1996
Transition from acute to maintenance treatment: prediction of stabilizationN R Schooler, J B Severe, I D Glick, et al.
Progress in Clinical and Biological Research|January 1, 1987
Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantationA Fefer, K M Sullivan, P Weiden, et al.
Progress in Clinical and Biological Research|January 1, 1987
Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantationK M Sullivan, A Fefer, R Witherspoon, et al.
Obstetrics and Gynecology|October 1, 1993
A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical responseA J Jacobs, M Fer, F M Su, et al.
CNS Spectrums|August 23, 2005
An innovative approach to clinical communication in schizophrenia: the approaches to schizophrenia communication checklistsS G Dott, P Weiden, P Hopwood, et al.
Pageof 3